Oční ordinace MUDr. Hanák, s.r.o.
- Address
- lock Available on a paid plan
Oční ordinace MUDr. Hanák, s.r.o.
Oční ordinace MUDr. Hanák, s.r.o. is a specialized ophthalmology center that participates in advanced clinical research, with particular focus on conditions affecting older adults. The center combines routine eye care with participation in innovative vaccine research studies, demonstrating expertise in long-term clinical monitoring and immunological response assessment.
- Herpes Zoster prevention and vaccine efficacy research
- Long-term safety and persistence studies in elderly populations
- Immune response monitoring and evaluation
The center's research involvement includes evaluating the efficacy of Herpes Zoster vaccines in preventing shingles in older adults, a condition that can have serious ocular complications. Through participation in studies examining vaccine effectiveness and long-term immune persistence, the center contributes valuable data to understanding preventive strategies for age-related infectious diseases that may impact vision and overall health in the geriatric population.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Oční ordinace MUDr. Hanák, s.r.o.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-term Evaluation of Efficacy, Safety, and Immune Response Persistence of Recombinant Varicella Zoster Virus Glycoprotein E Vaccine in Herpes Zoster Prevention in Older Adults | GlaxoSmithKline Biologicals | Phase III | Not Recruiting | Aug 2022 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Recombinant Varicella Zoster Virus Glycoprotein E | 1 | Unknown | 2022-08-08 | 2022-08-08 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.